SLS EBITDA Margin
Sellas Life Sciences Group Inc · EBITDA Margin
SLS EBITDA Margin
Latest reported-4084.40%period ending
SLS TTM EBITDA Margin (-6770.78% → -4084.40%)
TTM ebitda margin
High-resolution chart · PNG
SLS ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -4,084.3999% | |
| -3,740.7999% | |
| -3,767.7999% | |
| -1,171% | |
| -245.5132% | |
| -180.8316% | |
| -153.5368% | |
| -187.3684% | |
| -889.7368% | |
| 514.3509% | |
| 557.3712% | |
| 1,234.3636% | |
| -401.887% | |
| -359.3222% | |
| -463.7126% | |
| -522.5024% | |
| -666.5771% | |
| -658.0318% | |
| -823.9485% | |
| -1,342.501% | |
| -1,241.6434% | |
| -1,888.1752% | |
| -1,777.9075% | |
| -1,668.8564% | |
| -5,972.428% | |
| -6,089.3004% | |
| -7,109.8765% | |
| -6,770.7819% |